Maintenance Immunosuppression in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- 1 June 2011
- journal article
- editorial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 57 (6) , 818-821
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialAnnals of the Rheumatic Diseases, 2010
- Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisClinical Journal of the American Society of Nephrology, 2010
- The CLEAR StudyClinical Journal of the American Society of Nephrology, 2010
- Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetilArthritis & Rheumatism, 2010
- Can We Personalize Treatment for Kidney Diseases?Clinical Journal of the American Society of Nephrology, 2009
- Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvementClinical Nephrology, 2009
- Patterns of presentation and diagnosis of patients with Wegener's granulomatosis: ENT aspectsThe Journal of Laryngology & Otology, 2006
- Solid malignancies among patients in the Wegener's granulomatosis etanercept trialArthritis & Rheumatism, 2006
- Sequential Therapies for Proliferative Lupus NephritisNew England Journal of Medicine, 2004
- MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1997